MARKET WIRE NEWS

Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-05 11:23:10 ET

Fresenius Medical Care AG (FMS)

Q2 2025 Earnings Call

August 5, 2025 08:00 A.M. ET

Company Participants

s - Corporate Participant

o - Corporate Participant

P - Corporate Participant

Dominik Heger - Executive VP and Head of Investor Relations, Strategic Development & Communications

Helen Giza - Chair of Management Board & CEO

Martin Fischer - CFO & Member of the Management Board

Conference Call Participants

David James Adlington - JPMorgan Chase & Co, Research Division

Falko Friedrichs - Deutsche Bank AG, Research Division

Graham Doyle - UBS Investment Bank, Research Division

Hassan Al-Wakeel - Barclays Bank PLC, Research Division

Hugo Solvet - BNP Paribas Exane, Research Division

James Alexander Stewart Vane- Tempest - Jefferies LLC, Research Division

Oliver Metzger - ODDO BHF Corporate & Markets, Research Division

Richard Felton - Goldman Sachs Group, Inc., Research Division

Veronika Dubajova - Citigroup Inc., Research Division

a divi - Unidentified Company

ion - Unidentified Company

f S& - Global Inc. All Rights reserved.

Presentation

Operator

Ladies and gentlemen, welcome to the Report on Second Quarter 2025 Conference Call. I am Sandra, the Chorus Call operator. [Operator Instructions] and the conference is being recorded. [Operator Instructions]...

Read the full article on Seeking Alpha

For further details see:

Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript
Fresenius Med Care Ag Ord

NASDAQ: FMCQF

FMCQF Trading

0.0% G/L:

$49.2095 Last:

160 Volume:

$49.2095 Open:

mwn-link-x Ad 300

FMCQF Latest News

FMCQF Stock Data

$14,019,294,593
293,413,449
N/A
873
N/A
Healthcare Providers & Services
Healthcare
DE
Bad Homburg

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App